Best Long Term Companies To Own In Right Now

We often hear that people should invest in assets depending upon their risk taking ability. But the million dollar question is what is ones risk taking ability? Can a questionnaire alone decide how much risk one can take ? If so will it remain the same till one meets his goals?

The answer is indeed very tricky. This is so because our risk taking ability is decided by many external factors. For example when the markets perform well even risk averse investors start investing in the markets and when markets don't do well our portfolio tends to get skewed towards debt. Our risk taking ability also depends on factors like peer pressure, our past experience, our family background etc.

Risk taking ability should purely depend upon your milestones and your current financial condition. If the goals are Short term in nature then it is better to invest in fixed income bearing securities though other riskier options could look exciting. Similarly when the goals are long term in nature a certain amount of risk could be taken in order to improve our return on investments. The problem is that more often than not people lose focus of  their goals and start investing looking at the product features and immediate gains. In such conditions your  ability to take risks changes drastically. When this happens and the investments don't yield the desired result then the entire planning falls flat.

Best Long Term Companies To Own In Right Now: Credit Suisse Group AG (CSGN)

Credit Suisse Group AG is a Switzerland-based holding company engaged in private banking, investment banking and asset management areas. It operates through four divisions: Private Banking, which consists of the Wealth Management Clients and Corporate & Institutional Clients business; Investment Banking, provides a range of financial products and services, with a focus on client-driven, flow-based and capital-efficient businesses; Asset Management, offers a range of asset class products, including alternative investments, and multi-asset class solutions, including equities and fixed income products, and Shared Services, which provides centralized corporate services and business support for the Company's divisions. Advisors' Opinion:

• [By Sharon Cho]

  Growing demand for the most-stable equities has spurred a record 31 straight days of foreign inflows into South Korean shares, while concern over Federal Reserve tapering and America�� debt-ceiling debate sent the benchmark gauge of U.S. stock volatility to a three-month high on Oct. 8. Credit Suisse Group AG (CSGN), UBS Wealth Management and Bank Julius Baer & Co. say they��e bullish on South Korea as smaller price swings lure investors to companies from SK Hynix Inc. (000660) to LG Chem Ltd. (051910)

Best Long Term Companies To Own In Right Now: RBC Bearings Incorporated(ROLL)

RBC Bearings Incorporated manufactures and markets engineered precision plain, roller, and ball bearings primarily in North America, Europe, and Latin America. It operates in four segments: Plain Bearings, Roller Bearings, Ball Bearings, and Others. The Plain Bearings segment produces plain bearings with self-lubricating or metal-to-metal designs, including rod end bearings, spherical plain bearings, and journal bearings that are primarily used to rectify misalignments in various mechanical components. The Roller Bearings segment provides tapered roller bearings, needle roller bearings, and needle bearing track rollers and cam followers, which are anti-friction products that utilize cylindrical rolling elements. The Ball Bearings segment specializes in high precision aerospace, airframe control, thin section, and industrial ball bearings that utilize high precision ball elements to reduce friction in high speed applications. The Other segment consists of precision mechanic al components, which are used in various general industrial applications; and machine tool collets that are used for holding circular or rod-like pieces in a lathe or other machine. It serves construction and mining, oil and natural resource extraction, heavy truck, packaging, and semiconductor machinery; and aerospace and defense markets. The company offers its products through direct sales force and a network of industrial and aerospace distributors. RBC Bearings Incorporated is headquartered in Oxford, Connecticut.

Advisors' Opinion:

• [By Stephen Simpson, CFA]

  This is a logical deal for SKF on multiple fronts. For starters, Kaydon will meaningfully expand the company's U.S. presence - something it could have done on its own eventually, but certainly not without spending money. With that, there is the possibility of using Kaydon's existing U.S. footprint to sell more SKF products and further trouble rivals like RBC Bearings (ROLL) and ITT (ITT).

Top 5 Recreation Stocks To Watch Right Now: Rexahn Pharmaceuticals Inc (RNN)

Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company�� pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development. In addition, the Company has two renal cell carcinoma (CNS) candidates, Serdaxin, CNS Disorders drug for depression and neurodegenerative diseases and Zoraxel, which is a erectile dysfunction (ED) and sexual dysfunction drug that are in clinical stages and the Company is are exploring options for further development . The Company�� drug candidate, Archexin is an anticancer Akt inhibitor.

Archexin

Archexin is potent inhibitor of the Akt protein kinase (Akt) in cancer cells. Archexin has FDA orphan drug designations for five cancers (RCC, glioblastoma, and cancers of the ovary, stomach and pancreas). Multiple indications for other solid tumors can also be pursued. Archexin inhibit both activated and inactivated forms of Akt, and to reverse the drug resistance observed with the protein kinase inhibitors. Archexin is an antisense oligonucleotide (ASO) compound that is complementary to Akt mRNA, and selective for inhibiting mRNA expression and production of Akt protein. As of December 31, 2011, Archexin was in Phase II clinical trials for the treatment of pancreatic cancer with enrollment completed in September, 2011.

Serdaxin

Serdaxin is an extended release formulation of clavulanic acid, which is an ingredient present in antibiotics approved by the FDA. The Company had been developing Serdaxin for the treatment of depression and neurodegenerative disorders. From January to September, 2011, the Company conducted a randomized, double-blind, placebo-controlled study compared two doses of Serdaxin, 0.5 milligram and 5 milligram, to placebo over an eight-week treatment period for major depressive disorder (MDD) patients. As of Dec! ember 31, 2011, the Company had not made a determination of Serdaxin�� future paths or resource allocations to further develop Serdaxin to treat MDD.

Zoraxel

Zoraxel is an orally administered, on-demand tablet to treat sexual dysfunction. Zoraxel is a dual enhancer of neurotransmitters in the brain that play a key role in sexual activity phases of motivation and arousal, erection and release, and may be the ED drug to affect all three of these phases of sexual activity. As of December 31, 2011, the Company was evaluating how to proceed with the Phase IIb study of Zoraxel.

The Company�� Pre-clinical Pipeline Drug Candidates includes RX-1792, which is a small molecule anticancer EGFR inhibitor; RX-5902, which is a small molecule anticancer ribonucleic acid (RNA) helicase regulator; RX-3117, which is a Small molecule anticancer deoxyribonucleic acid (DNA) synthesis Inhibitor; RX-8243, which is a small molecule anticancer aurora kinase inhibitor; RX-0201-Nano, which is a nanoliposomal anticancer Akt inhibitor; RX-0047-Nano, which is an nanoliposomal anticancer HIF-1 alpha inhibitor and RX-21101, which is a nano-polymer Anticancer.

Advisors' Opinion:

• [By John Udovich]

  So far this year, Rexahn Pharmaceuticals, Inc (NYSEMKT: RNN), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and Arrowhead Research Corp (NASDAQ: ARWR) are up 186.3%, 157.2% and 142.5%, respectively, since the start of the year���making them the best performing small cap biotech stocks for 2014. But given their lackluster performance over the past few years, what is the secret behind their phenomenal 2014 rise and will they keep rising? For starters, none of these small caps have really produced anything in the way of blockbuster news:

• [By James E. Brumley]

  With just a quick glance at a chart of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), it would be easy to conclude it's nothing but a volatile mess. When you take a step back and look at a long-term weekly chart of RNN, however, it starts to become clear that this small cap biopharma name is on the verge of a monster-sized breakout. First things first, however.

• [By Roberto Pedone]

  One under-$10 biopharmaceutical player that's just starting to move into breakout territory is Rexahn Pharmaceuticals (RNN), which is engaged in the development of novel treatments for cancer to patients. This stock has been on fire so far in 2013, with shares up sharply by 62%.

  If you take a look at the chart for Rexahn Pharmaceuticals, you'll notice that this stock has been uptrending strong for the last month, with shares moving higher from its low of 36 cents per share to its intraday high of 53 cents per share. During that uptrend, shares of RNN have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of RNN into breakout territory above some near-term overhead resistance levels at 49 cents to 50 cents per share. It's worth noting that volume today is tracking in extremely strong with over 3 million shares traded, versus its three-month average action of 1.22 million shares.

  Traders should now look for long-biased trades in RNN if it manages to break out above Thursday's intraday high of 53 cents per share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.22 million shares. If that breakout hits soon, then RNN will set up to re-test or possibly take out its next major overhead resistance levels at 64 cents to its 52-week high at 66 cents per share. Any high-volume move above 66 cents to 67 cents per share could then send RNN towards its next major overhead resistance levels at 81 cents per share.

  Traders can look to buy RNN off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average at 47 cents per share. One can also buy RNN off strength once it clears 53 cents per share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By James E. Brumley]

  At first glance, Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) doesn't look like anything particularly trade-worthy. The stock's now where it was in late October, and where it was in late September, and even where it was in late June. In other words, though RNN has been much higher and much lower than its current price of $0.46 over the course of the past several months, it doesn't look like it's going anywhere - on a net basis - anytime.

Best Long Term Companies To Own In Right Now: Volkswagen AG (VLKAF.PK)

Volkswagen AG is a Germany-based automobile manufacturer. The Company develops vehicles and components, and also produces and sells vehicles, in particular Volkswagen brand passenger cars and commercial vehicles. The Company consists of two divisions: Automotive and Financial Services division. The Automotive division is responsible for the development of vehicles and engines, the production and sale of passenger cars, commercial vehicles, trucks and buses, and the genuine parts business. The Financial services division's portfolio of services includes dealer and customer services in the field of financing, leasing, direct bank, insurance and fleet business. The Company's brands include Volkswagen, Audi, Bentley, Bugatti, Lamborghini, SEAT, Skoda, Scania and Volkswagen Commercial Vehicles and each brand offers a product range from low-consumption small cars to luxury class vehicles, as well as pick ups, busses and heavy trucks in the commercial vehicle sector. Advisors' Opinion:

• [By Yasir Idrees]

  Nokia has already taken its Here platform to the next level after it announced the Here Connected Driving service. The Here rebranding strategy of extending Nokia's location services has helped the company reach deals with companies like BMW, Mercedes and Volkswagen (VLKAF.PK) and Connected Driving is what takes this to the next level.

Best Long Term Companies To Own In Right Now: Powershares Golden Dragon (PGJ)

PowerShares Golden Dragon Halter USX China Portfolio is based on the Halter USX China Index. The Index is comprised of the United States listed securities of companies, which derive a majority of their revenue from the People's Republic of China. The fund was incepted on December 9, 2004.

The sectors covered by the investment include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, materials, telecommunications and utilities. PowerShares Capital Management LLC provides investment management to the Fund.

Advisors' Opinion:

• [By Robert Martin]

  With that in mind, here are four of the best emerging market ETF picks: A China ETF, an India ETF, and two other ETFs that track broad indices like the MSCI Emerging Markets Index.

  PowerShares Gold Dragon Halter USX China Portfolio (PGJ)

  Expense Ratio: 0.7%

Best Long Term Companies To Own In Right Now: Alleghany Corporation(Y)

Alleghany Corporation, through its subsidiaries, engages in the property and casualty, and surety insurance business in the United States. It underwrites specialty insurance coverages in the property, umbrella/excess, general liability, directors and officers liability, professional liability lines of business, and homeowners insurance. The company also writes surety products, such as commercial surety bonds and contract surety bonds. In addition, Alleghany Corporation owns and manages improved and unimproved commercial land, and residential lots in the Sacramento, California. As of December 31, 2010, the company owned approximately 320 acres of property in various land use categories. Further, it engages in the oil and gas exploration and production business. The company was founded in 1929 and is based in New York, New York.

Advisors' Opinion:

• [By Chris Hill]

  Which investors are worth following? In this installment of MarketFoolery, our analysts talk about why they're following Cook and Bynum's Richard Cook and Dowe Bynum, Martin Capital's Frank Martin, Alleghany's (NYSE: Y  ) CEO Weston Hicks, and T. Rowe Price's (NASDAQ: TROW  ) �Preston Athey.�

Best Long Term Companies To Own In Right Now: Zogenix Inc (ZGNX)

Zogenix, Inc. (Zogenix), incorporated on May 11, 2006, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. The Company�� product Sumavel DosePro offers needle-free subcutaneous administration of sumatriptan for the treatment of migraine and cluster headache in a pre-filled, single-use delivery system. Its lead product candidate, Zohydro (hydrocodone bitartrate, formerly ZX002) is a 12-hour extended-release formulation of hydrocodone without acetaminophen for the treatment of chronic pain requiring opioid therapy. It completed Phase 3 development of Zohydro in 2011. Its second DosePro investigational product candidate, Relday, is a injectable formulation of risperidone for the treatment of schizophrenia. Sumavel DosePro and Zohydro are used for the treatment options available to patients and physicians in the United States. Sumavel DosePro may serve as a treatment alternative to oral and nasal triptans and offers administration when compared to traditional, needle-based sumatriptan injection. In May, 2012, it submitted a New Drug Application to the Food and Drug Administration (FDA).

The Company�� collaboration with Astellas has been terminated on March 31, 2012. Sumavel DosePro is a pre-filled, single-use disposable, needle-free drug delivery system that subcutaneously delivers 6 mg of sumatriptan in 0.5 mL of sterile liquid. Sumavel DosePro is designed to be portable, intuitive and easy-to-use. To use, the patient simply snaps off a plastic tip, flips back a lever and presses the end of the delivery system to the skin of the abdomen or thigh. Under the force of a small amount of compressed nitrogen gas, the liquid form of sumatriptan is expelled out of the device as a thin jet of medication, which pierces the skin and selectively deposits into the subcutaneous tissue.

Zogenix competes with GlaxoSmithKline, AstraZeneca PLC, Endo Pharmaceuticals Holdings Inc., Johnson & Johnson, Merck & Co., ! Inc., Pfizer Inc., Alexza Pharmaceuticals, Inc., MAP Pharmaceuticals, Inc., Abbott Laboratories, Alpharma Inc., Endo Pharmaceuticals Holdings Inc., King Pharmaceuticals, Inc., Mallinckrodt Inc., Purdue Pharma L.P., Teva Pharmaceutical Industries Limited, Watson Pharmaceuticals, Inc., Becton, Dickinson and Company, Owen Mumford Ltd., Ypsomed, Sandoz Inc., Bioject Inc. and Antares Pharma Inc.

Advisors' Opinion:

• [By Lauren Pollock]

  The Food and Drug Administration approved an extended-release version of the narcotic painkiller hydrocodone despite a recommendation by its advisory committee that the drug should be rejected because of its potential for abuse. The federal agency approved Zohydro ER from Zogenix Inc.(ZGNX), the first hydrocodone product not mixed with milder painkillers such as acetaminophen and also the first extended-release hydrocodone product. Shares rose 15% to $3.49 premarket.

Best Long Term Companies To Own In Right Now: ArthroCare Corporation(ARTC)

ArthroCare Corporation, a medical device company, develops, manufactures, and markets surgical products primarily based on its minimally invasive patented Coblation technology in the Americas and internationally. The company?s Sports Medicine business provides energy-based systems and fixation technologies used to treat soft tissue injuries in the shoulders, knees, and hips. It offers ArthroWands product line that features Coblation based specialized disposable energy-based surgical wands designed for single patient use to treat orthopedic conditions, including shoulder, knee, hip, foot, ankle, elbow, and wrist injuries; and Soft-Tissue Fixation products comprising a line of specialized implants and instruments, such as knotless and traditional anchors for rotator cuff and labrum repairs in shoulder; screws for ligament reconstruction in knee; a range of arthroscopic suture passers; and reusable hand-held instruments, procedural kits, and accessories. The company?s Ear N ose and Throat (ENT) business provides surgical products used to treat conditions performed by ENT healthcare professionals. It offers various products for general head, neck, and oral surgical procedures, including sinus surgery, snoring treatment, nasal turbinates reduction, and adenoid and tonsil removal. The company also provides surgical products for the treatment of spine related and other conditions. Its products include SpineWand devices used to treat soft tissue conditions in spine; Plasma Disc Decompression products for treating contained herniated discs; Cavity SpineWand that reduces the size of malignant lesions in the vertebrae of patients suffering from spinal compression fractures; and WoundWand for acute and chronic wound debridement, and wound cleansing. ArthroCare sells its products to surgeons and specialized medical professionals through sales representatives, and independent sales agents and distributors. The company was founded in 1993 and is headquarte red in Austin, Texas.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Top Headline
  Smith & Nephew PLC (NYSE: SNN) announced its plans to buy ArthroCare (NASDAQ: ARTC) for $1.7 billion in cash. Smith & Nephew will pay $48.25 per share in cash to acquire ArthroCare, representing a 6.3% premium to ArthroCare's closing price on January 31.

Best Long Term Companies To Own In Right Now: OCI Partners LP (OCIP)

OCI Partners LP, incorporated on February 07, 2013, owns and operates an integrated methanol and ammonia production facility that is strategically located on the Texas Gulf Coast near Beaumont. The Company is a methanol producer in the United States with an annual methanol production capacity of approximately 730,000 metric tons and an annual ammonia production capacity of approximately 265,000 metric tons, and it is in the early stages of a debottlenecking project that increases its annual methanol production capacity by 25% to approximately 912,500 metric tons and its annual ammonia production capacity by 15% to approximately 305,000 metric tons.

Both methanol and ammonia are global commodities that are essential building blocks for numerous end-use products. Methanol is a liquid petrochemical that is used in a variety of industrial and energy-related applications. Methanol is used in industrial applications to produce adhesives used in manufacturing wood products, such as plywood, particle board and laminates, resins to treat paper and plastic products, paint and varnish removers, solvents for the textile industry and polyester fibers for clothing and carpeting. Methanol is also used outside of the United States as a direct fuel for automobile engines, as a fuel blended with gasoline and as an octane booster in reformulated gasoline. In the United States, ammonia is primarily used as a feedstock to produce nitrogen fertilizers, such as urea and ammonium sulfate, and is also directly applied to soil as a fertilizer. In addition, ammonia is widely used in industrial applications, particularly in the Texas Gulf Coast market, including in the production of plastics, synthetic fibers, resins and numerous other chemical compounds.

Advisors' Opinion:

• [By Robert Rapier]

  Also speaking will be the leaders of some of the world�� leading methanol producers. Among them will be Egyptian billionaire Nassef Sawiris, the CEO of Orascom Construction Industries (OCI N.V.), a Netherlands-listed chemicals, fertilizer and construction conglomerate. OCI also happens to be the sponsor of OCI Partners (NYSE: OCIP), a master limited partnership (MLP) producing methanol and ammonia at a single plant on the Texas Gulf coast. The facility was mothballed in 2004 amid high natural gas prices, and restarted in 2012 by OCI N.V.

• [By Paul Ausick]

  Stocks on the Move: Potbelly Corp. (NASDAQ: PBPB) is up 119.1% at $30.68 after a blistering IPO at $14 a share. OCI Partners LP (NYSE: OCIP) is up 5.6% at $19.01 after an IPO at $18.00 a share. Cherry Hill Mortgage Investment Corp. (NYSE: CHMI) is down 7.6% at $18.48 following its IPO on Friday morning. Discovery Laboratories Inc. (NASDAQ: DSCO) is up 37.1% at $2.70 following approval of updated specifications for a drug to prevent respiratory distress in premature infants. Forest Oil Corp. (NYSE: FST) is down 9.7% at $5.74 following the sale of $1 billion worth of assets in the Texas panhandle.

• [By Robert Rapier]

  OCI Partners (Nasdaq: OCIP) owns and operates OCI Beaumont, an integrated methanol and ammonia production facility on the Texas Gulf Coast. OCI Beaumont has a methanol production capacity of 730,000 metric tons (MT) per year and an ammonia production capacity of 265,000 MT per year. The facility is in the middle of a debottlenecking project that will increase its annual methanol production capacity by 25 percent and its annual ammonia production capacity by 15 percent.

Best Long Term Companies To Own In Right Now: Trex Company Inc.(TREX)

Trex Company, Inc. manufactures and distributes wood/plastic composite products, and related accessories primarily for the residential and commercial decking and railing applications in the United States. The company offers decking products, including Trex Transcend and Trex Enhance protective shells for protection against fading, staining, and scratching; Trex Accents that provides a smooth surface on one side and subtle wood grain on the other; Trex Escapes, a cellular PVC deck board; and Trex Hideaway, a hidden fastening system for specially grooved boards. It also provides railing products comprising Trex Designer Series Railing, which consists of a decorative top and bottom rail, refined balusters, and post caps and skirts; and Trex Transcend Railing for use with Trex decking products, as well as other decking materials. In addition, the company offers Trex Transcend Porch Flooring and Railing System, an integrated system of porch components and accessories; and fenci ng products, such as Trex Seclusions fencing product that uses interlocking pickets for privacy, and Trex Surroundings fencing that uses traditional pickets. Further, it provides TrexTrim product, a cellular PVC residential exterior trim product; steel deck framing systems under Trex Elevations name; and Trex DeckLighting, a line of energy-efficient LED dimmable deck lighting, which is designed for use on posts, floors, and steps. Additionally, the company acts as a licensor in various licensing agreements with third parties to manufacture and sell various products, including Trex Outdoor Furniture; Trex RainEscape, an above joist deck drainage system; Trex CustomCurve, an on-site system that allows contractors to heat and bend Trex products; and Trex Pergolas, a cellular PVC trim product. The company sells its products through wholesale distributors, retail lumber dealers, and Home Depot and Lowe?s stores. Trex Company, Inc. was founded in 1996 and is headquartered in Winc hester, Virginia.

Advisors' Opinion:

• [By Rick Munarriz]

  The report naturally bodes well for Trex (NYSE: TREX  ) . The leading provider of wood-alternative decking posts next week, and what's good for one has been good for the other. Trex has also blasted through Wall Street estimates, beating quarterly profit targets by a double-digit percentage margin every single period over the past year.

• [By Jason Hall]

  Tesla Motors (NASDAQ: TSLA  ) �and Trex� (NYSE: TREX  ) have almost nothing in common. One is an innovative leader with expertise in a product that reduces greenhouse gas emissions versus its competitors, generally caters to an upscale clientele, and grew like crazy last year.�

• [By Rick Munarriz]

  Trex (NYSE: TREX  ) reports on Friday morning. The leading player in wood-alternative decking materials has benefited from a recent home-improvement boom, and it's been easily surpassing Wall Street's profit targets over the past year by double-digit percentage margins. Trex business also tends to pick up this time of year, as homeowners take on projects to replace or build outdoor patio decks as the warm weather kicks in.

• [By Rick Munarriz]

  Shares of Trex (NYSE: TREX  ) hit an eight-year high today after posting blowout quarterly results this morning.

  The leading maker of wood-alternative decking and railing products saw its net sales climb 12% to $107.9 million, exceeding both the $107.4 million that analysts were targeting and its own earlier guidance of $107 million.